Menu

Blog

Page 10602

Dec 23, 2016

A history of global living conditions in 5 charts

Posted by in category: life extension

To understand if the world is getting worse you have to look at the past data to see. So many people suggest we are heading for dystopia especially when talking about increased lifespans through technology but this doesnt really measure up against the facts. Life has never been so good and worth fighting for!


A common objection to increased lifespans is that the world is either already a horrible place or heading into some kind of sci-fiction dystopia not worth living. There are problems in the world but this article shows just how much science and technology has improved lives for decades.

The truth is there are problems in the world but nothing that we cannot overcome if we try. The world is a wonderful place, there is every reason to want to be alive and experience it and technology could let us live longer to enjoy it even more.

Continue reading “A history of global living conditions in 5 charts” »

Dec 23, 2016

Positive multiple sclerosis clinical trial suggests ‘unprecedented’ effects in relapsing form of the disease

Posted by in category: biotech/medical

More progress in treating MS.


In findings that show the effectiveness of a new strategy for treating multiple sclerosis (MS), researchers are reporting positive results from three large, international, multicenter Phase III clinical trials of the investigational drug ocrelizumab (brand name Ocrevus) in both relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).

The trial results are published online on Dec. 21, 2016, in The New England Journal of Medicine (NEJM), and are discussed in an accompanying editorial.

Continue reading “Positive multiple sclerosis clinical trial suggests ‘unprecedented’ effects in relapsing form of the disease” »

Dec 23, 2016

Seven robots you need to know

Posted by in categories: cyborgs, robotics/AI

From soft exoskeletons to cloud-based, networked ‘brains’, these are the 7 robots pointing the way to the future #ftrobots

Read more

Dec 23, 2016

How We Got Closer to Our Cyberhuman Future in 2016

Posted by in categories: biotech/medical, cyborgs

https://youtube.com/watch?v=Gb8H8aFAp5I

Humans’ relationship with technology is growing ever-more intimate. In a sense, we have already become cyborgs, tethered to our external electronic devices, outsourcing to them our memories, our sense of direction, our socializing, our lives. But, if the past year’s technological advancements are any indication, our relationship with technology is going to get a whole lot closer. Technology could one day soon become regularly integrated with our biology to manage disease and augment human ability. Here were some of the biggest breakthroughs of the past year on the cyborg front.

Read more

Dec 22, 2016

Advanced Tissue Biofabrication (ATB) Manufacturing USA Institute Will Focus on 3D Bioprinting Among Other Biofabrication Technologies

Posted by in categories: 3D printing, bioprinting, economics, government, security

logo-header

There’s really no sector in the United States (or much of the world) that has been untouched by the development of advanced manufacturing technologies – and no one seems to be underestimating the importance of the further development of those technologies in order to keep the country competitive. To that end, in 2014 the government established the National Network for Manufacturing Innovation (NNMI), more commonly known as Manufacturing USA.

The program brought together the industrial, academic, nonprofit and governmental sectors to establish a network of advanced manufacturing institutes for the purpose of accelerating new manufacturing technologies. President Obama proposed that the network grow to 45 institutes over the course of 10 years, and as of today, 12 have been established. The 12th, which was just announced by the Department of Defense, will be the Advanced Tissue Biofabrication (ATB) Manufacturing USA Institute, and will be led by the Advanced Regenerative Manufacturing Institute (ARMI), based in Manchester, New Hampshire.

Continue reading “Advanced Tissue Biofabrication (ATB) Manufacturing USA Institute Will Focus on 3D Bioprinting Among Other Biofabrication Technologies” »

Dec 22, 2016

Tech luminaries we lost in 2016

Posted by in category: futurism

We say a fond farewell to 18 men and women who left a lasting impression on the tech industry.

Read more

Dec 22, 2016

US Military Test-Fires SM-6 Weapons in Missile Defense Test

Posted by in category: military

The US Missile Defense Agency and Navy have test-launched two SM-6 missiles in a ballistic missile defense test. See the photos here.

Read more

Dec 22, 2016

Can technology stop another truck attack?

Posted by in categories: security, transportation

LONDON The attack on a Berlin Christmas market showed the devastation that can be wrought by the simple act of driving a truck into crowds, and the problems in preventing another massacre.

The attack in Germany on Monday, in which 11 people were killed by the truck in addition to the murder of the Polish driver, mirrored a militant raid in the French city of Nice in July that killed 86.

Hauliers increasingly track their vehicles in real time but security experts say the technology cannot be used to stop an attack if a lorry has been hijacked to be used as a weapon.

Read more

Dec 22, 2016

The world’s first demonstration of spintronics-based artificial intelligence

Posted by in categories: particle physics, robotics/AI

Excellent.


Researchers at Tohoku University have, for the first time, successfully demonstrated the basic operation of spintronics-based artificial intelligence.

Artificial intelligence, which emulates the information processing function of the brain that can quickly execute complex and complicated tasks such as image recognition and weather prediction, has attracted growing attention and has already been partly put to practical use.

Continue reading “The world’s first demonstration of spintronics-based artificial intelligence” »

Dec 22, 2016

Artificial intelligence to generate new cancer drugs on demand

Posted by in categories: biotech/medical, business, robotics/AI

Summary:

  • Clinical trial failure rates for small molecules in oncology exceed 94% for molecules previously tested in animals and the costs to bring a new drug to market exceed $2.5 billion
  • There are around 2,000 drugs approved for therapeutic use by the regulators with very few providing complete cures
  • Advances in deep learning demonstrated superhuman accuracy in many areas and are expected to transform industries, where large amounts of training data is available
  • Generative Adversarial Networks (GANs), a new technology introduced in 2014 represent the “cutting edge” in artificial intelligence, where new images, videos and voice can be produced by the deep neural networks on demand
  • Here for the first time we demonstrate the application of Generative Adversarial Autoencoders (AAEs), a new type of GAN, for generation of molecular fingerprints of molecules that kill cancer cells at specific concentrations
  • This work is the proof of concept, which opens the door for the cornucopia of meaningful molecular leads created according to the given criteria
  • The study was published in Oncotarget and the open-access manuscript is available in the Advance Open Publications section
  • Authors speculate that in 2017 the conservative pharmaceutical industry will experience a transformation similar to the automotive industry with deep learned drug discovery pipelines integrated into the many business processes
  • The extension of this work will be presented at the “4th Annual R&D Data Intelligence Leaders Forum” in Basel, Switzerland, Jan 24-26th, 2017

Thursday, 22nd of December Baltimore, MD — Scientists at the Pharmaceutical Artificial Intelligence (pharma. AI) group of Insilico Medicine, Inc, today announced the publication of a seminal paper demonstrating the application of generative adversarial autoencoders (AAEs) to generating new molecular fingerprints on demand. The study was published in Oncotarget on 22nd of December, 2016. The study represents the proof of concept for applying Generative Adversarial Networks (GANs) to drug discovery. The authors significantly extended this model to generate new leads according to multiple requested characteristics and plan to launch a comprehensive GAN-based drug discovery engine producing promising therapeutic treatments to significantly accelerate pharmaceutical R&D and improve the success rates in clinical trials.

Read more